Literature DB >> 16513081

The expressions of insulin-like growth factors, their receptors, and binding proteins are related to the mechanism regulating masseter muscle mass in the rat.

T Matsumoto1, S Akutsu, N Wakana, M Morito, A Shimada, A Yamane.   

Abstract

OBJECTIVE: The mechanism regulating skeletal muscle mass is unclear. The purpose of the present study was to investigate the extent to which insulin-like growth factors (IGFs), their receptors (IGFRs), and binding proteins (IGFBPs) are involved in the regulation of skeletal muscle mass.
DESIGN: We measured the mRNA expression levels for IGFs, IGFRs, and IGFBPs in the rat masseter muscle hypertrophied by oral administration of clenbuterol for 3 weeks and determined the correlations between the weight of masseter muscle and the mRNA expression levels.
RESULTS: The mRNA expression levels for IGF-I and II, IGFR1 and 2, and IGFBP4 and 6 showed clenbuterol-induced elevations and positive correlations with the weight of masseter muscle. That for IGFBP3 only exhibited a clenbuterol-induced decrease and a strong negative correlation with the weight of masseter muscle. The mRNA expression levels for IGFBP2 and 5 showed no significant changes between the control and clenbuterol groups, and no significant correlations. IGFBP1 mRNA was not detectable.
CONCLUSION: These results suggest that IGF-I, II, IGFR1 and 2, and IGFBP3, 4 and 6 are related to the mechanism regulating masseter muscle mass in the rat.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16513081     DOI: 10.1016/j.archoralbio.2006.01.003

Source DB:  PubMed          Journal:  Arch Oral Biol        ISSN: 0003-9969            Impact factor:   2.633


  10 in total

1.  Salmeterol with Liver Depot Gene Therapy Enhances the Skeletal Muscle Response in Murine Pompe Disease.

Authors:  Sang-Oh Han; Songtao Li; Jeffrey I Everitt; Dwight D Koeberl
Journal:  Hum Gene Ther       Date:  2019-04-05       Impact factor: 5.695

2.  Evaluation of antihypertensive drugs in combination with enzyme replacement therapy in mice with Pompe disease.

Authors:  Sang-Oh Han; Alexina C Haynes; Songtao Li; Dennis M Abraham; Priya S Kishnani; Richard Steet; Dwight D Koeberl
Journal:  Mol Genet Metab       Date:  2019-10-17       Impact factor: 4.797

3.  Salmeterol enhances the cardiac response to gene therapy in Pompe disease.

Authors:  Sang-Oh Han; Songtao Li; Dwight D Koeberl
Journal:  Mol Genet Metab       Date:  2016-03-18       Impact factor: 4.797

4.  Correction of Biochemical Abnormalities and Improved Muscle Function in a Phase I/II Clinical Trial of Clenbuterol in Pompe Disease.

Authors:  Dwight D Koeberl; Laura E Case; Edward C Smith; Crista Walters; Sang-Oh Han; Yanzhen Li; Wei Chen; Christoph P Hornik; Kim M Huffman; William E Kraus; Beth L Thurberg; David L Corcoran; Deeksha Bali; Nenad Bursac; Priya S Kishnani
Journal:  Mol Ther       Date:  2018-07-05       Impact factor: 11.454

5.  Adjunctive β2-agonists reverse neuromuscular involvement in murine Pompe disease.

Authors:  Songtao Li; Baodong Sun; Mats I Nilsson; Andrew Bird; Mark A Tarnopolsky; Beth L Thurberg; Deeksha Bali; Dwight D Koeberl
Journal:  FASEB J       Date:  2012-09-19       Impact factor: 5.191

6.  β2 Agonists enhance the efficacy of simultaneous enzyme replacement therapy in murine Pompe disease.

Authors:  Dwight D Koeberl; Songtao Li; Jian Dai; Beth L Thurberg; Deeksha Bali; Priya S Kishnani
Journal:  Mol Genet Metab       Date:  2011-11-11       Impact factor: 4.797

7.  Enhanced efficacy of enzyme replacement therapy in Pompe disease through mannose-6-phosphate receptor expression in skeletal muscle.

Authors:  Dwight D Koeberl; Xiaoyan Luo; Baodong Sun; Alison McVie-Wylie; Jian Dai; Songtao Li; Suhrad G Banugaria; Y-T Chen; Deeksha S Bali
Journal:  Mol Genet Metab       Date:  2011-02-13       Impact factor: 4.797

8.  Efficacious Androgen Hormone Administration in Combination with Adeno-Associated Virus Vector-Mediated Gene Therapy in Female Mice with Pompe Disease.

Authors:  Sang-Oh Han; Dorothy Gheorghiu; Alex Chang; Sweet Hope Mapatano; Songtao Li; Elizabeth Brooks; Dwight Koeberl
Journal:  Hum Gene Ther       Date:  2022-05-04       Impact factor: 4.793

9.  Synergistic Efficacy from Gene Therapy with Coreceptor Blockade and a β2-Agonist in Murine Pompe Disease.

Authors:  Sang-oh Han; Songtao Li; Andrew Bird; Dwight Koeberl
Journal:  Hum Gene Ther       Date:  2015-09-29       Impact factor: 5.695

10.  Effects of clenbuterol, a β₂-adrenergic agonist, on sizes of masseter, temporalis, digastric, and tongue muscles.

Authors:  Chieko Ishikawa; Takumi Ogawa; Tomoko Ikawa; Akira Yamane
Journal:  Open Dent J       Date:  2009-09-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.